Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-12

Clinical Trial Update: Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis

View source ↗

Summary

Completed clinical trial update describing approaches to monitoring early disease progression in hereditary transthyretin amyloidosis. The study addresses progr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The Cleveland Clinic | Conditions: Amyloidosis, Amyloid | Status: COMPLETED